3 November 2025 (Monday) - A.P.L.

 

Acute promyelocytic leukaemia…  There’s some pictures here and an article about how the condition is best treated here.
 
Oh… Statements 1, 3, and 4 are correct.
The images given show dumbbell-shaped blasts consistent with acute promyelocytic leukemia (APL), a subtype of AML known for its aggressive presentation and high risk of bleeding and/or thrombosis due to coagulopathy. Unlike other AML variants, APL often leads to disseminated intravascular coagulation (DIC), supported by lab findings such as elevated INR, prolonged aPTT, low fibrinogen, and high D-dimer.
Despite its favorable long-term prognosis, APL is a hematologic emergency requiring urgent treatment.  The coagulopathy in APL is primarily driven by tissue factor (TF) released during promyelocyte destruction, triggering excessive activation of the coagulation cascade. With the advent of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) as frontline therapy, APL has become the most curable AML subtype. APL blasts are typically negative for HLA-DR and CD34, distinguishing them from other AML variants.

No comments:

Post a Comment